NO20071616L - Benzoksazin- og kinoksalinderivater og anvendelser - Google Patents
Benzoksazin- og kinoksalinderivater og anvendelserInfo
- Publication number
- NO20071616L NO20071616L NO20071616A NO20071616A NO20071616L NO 20071616 L NO20071616 L NO 20071616L NO 20071616 A NO20071616 A NO 20071616A NO 20071616 A NO20071616 A NO 20071616A NO 20071616 L NO20071616 L NO 20071616L
- Authority
- NO
- Norway
- Prior art keywords
- cinoxaline
- benzoxazine
- derivatives
- medicaments
- manufacture
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/536—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines ortho- or peri-condensed with carbocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
- C07D265/34—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings
- C07D265/36—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings condensed with one six-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Neurosurgery (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US61470504P | 2004-09-30 | 2004-09-30 | |
| US63060804P | 2004-11-24 | 2004-11-24 | |
| PCT/EP2005/010238 WO2006037481A1 (en) | 2004-09-30 | 2005-09-22 | Benzoxazine and quinoxaline derivatives and uses |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20071616L true NO20071616L (no) | 2007-04-25 |
Family
ID=35385358
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20071616A NO20071616L (no) | 2004-09-30 | 2007-03-27 | Benzoksazin- og kinoksalinderivater og anvendelser |
Country Status (17)
| Country | Link |
|---|---|
| EP (1) | EP1797051B1 (de) |
| JP (1) | JP2008514662A (de) |
| KR (1) | KR100875041B1 (de) |
| AR (1) | AR051115A1 (de) |
| AT (1) | ATE477248T1 (de) |
| AU (1) | AU2005291541B2 (de) |
| BR (1) | BRPI0516754A (de) |
| CA (1) | CA2581921A1 (de) |
| DE (1) | DE602005022896D1 (de) |
| IL (1) | IL182304A0 (de) |
| MX (1) | MX2007003911A (de) |
| MY (1) | MY139409A (de) |
| NO (1) | NO20071616L (de) |
| NZ (1) | NZ553848A (de) |
| RU (1) | RU2382036C2 (de) |
| TW (1) | TW200626567A (de) |
| WO (1) | WO2006037481A1 (de) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2301625B1 (de) * | 2004-09-30 | 2017-07-19 | F. Hoffmann-La Roche AG | Zusammensetzungen und verfahren zur behandlung kognitiver störungen |
| CL2007003044A1 (es) * | 2006-10-24 | 2008-07-04 | Wyeth Corp | Compuestos derivados de benzoxazina; composicion farmaceutica que los comprende; y uso para el tratamiento de un trastorno psicotico, bipolar, depresivo y abuso o dependencia de sustancias entre otros. |
| BRPI0920520A2 (pt) * | 2008-09-08 | 2015-12-22 | Hoffmann La Roche | benzoxazinas 5-subistituídas |
| CA2953004C (en) * | 2014-07-08 | 2023-02-21 | Sunshine Lake Pharma Co., Ltd. | Aromatic heterocyclic derivatives and pharmaceutical applications thereof |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW224941B (de) * | 1989-11-08 | 1994-06-11 | Yamanouchi Pharma Co Ltd | |
| KR20010108025A (ko) * | 1998-12-17 | 2001-12-07 | 이곤 이 버그 | 5ＨＴ2Ｃ 효능제인2,3,4,4ａ-테트라하이드로-1Ｈ-피라지노(1,2-ａ)퀴녹살린-5(6Ｈ)온 유도체 |
| WO2003029238A1 (en) * | 2001-10-04 | 2003-04-10 | Wyeth | Chroman derivatives as 5-hydroxytryptamine-6 ligands |
| WO2003095434A1 (en) * | 2002-05-13 | 2003-11-20 | F. Hoffmann-La Roche Ag | Benzoxazine derivatives as 5-ht6 modulators and uses thereof |
| EP2301625B1 (de) * | 2004-09-30 | 2017-07-19 | F. Hoffmann-La Roche AG | Zusammensetzungen und verfahren zur behandlung kognitiver störungen |
-
2005
- 2005-09-22 RU RU2007110479/04A patent/RU2382036C2/ru not_active IP Right Cessation
- 2005-09-22 JP JP2007533918A patent/JP2008514662A/ja active Pending
- 2005-09-22 CA CA002581921A patent/CA2581921A1/en not_active Abandoned
- 2005-09-22 EP EP05796666A patent/EP1797051B1/de active Active
- 2005-09-22 BR BRPI0516754-0A patent/BRPI0516754A/pt not_active IP Right Cessation
- 2005-09-22 DE DE602005022896T patent/DE602005022896D1/de active Active
- 2005-09-22 MX MX2007003911A patent/MX2007003911A/es active IP Right Grant
- 2005-09-22 KR KR1020077007227A patent/KR100875041B1/ko not_active IP Right Cessation
- 2005-09-22 WO PCT/EP2005/010238 patent/WO2006037481A1/en active Application Filing
- 2005-09-22 AU AU2005291541A patent/AU2005291541B2/en not_active Expired - Fee Related
- 2005-09-22 AT AT05796666T patent/ATE477248T1/de active
- 2005-09-22 NZ NZ553848A patent/NZ553848A/en not_active IP Right Cessation
- 2005-09-27 TW TW094133563A patent/TW200626567A/zh unknown
- 2005-09-27 AR ARP050104050A patent/AR051115A1/es unknown
- 2005-09-28 MY MYPI20054561A patent/MY139409A/en unknown
-
2007
- 2007-03-27 NO NO20071616A patent/NO20071616L/no not_active Application Discontinuation
- 2007-03-29 IL IL182304A patent/IL182304A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AR051115A1 (es) | 2006-12-20 |
| IL182304A0 (en) | 2007-07-24 |
| EP1797051B1 (de) | 2010-08-11 |
| AU2005291541B2 (en) | 2011-03-10 |
| KR20070047844A (ko) | 2007-05-07 |
| MX2007003911A (es) | 2007-05-21 |
| MY139409A (en) | 2009-09-30 |
| KR100875041B1 (ko) | 2008-12-19 |
| JP2008514662A (ja) | 2008-05-08 |
| ATE477248T1 (de) | 2010-08-15 |
| CA2581921A1 (en) | 2006-04-13 |
| TW200626567A (en) | 2006-08-01 |
| WO2006037481A1 (en) | 2006-04-13 |
| AU2005291541A1 (en) | 2006-04-13 |
| EP1797051A1 (de) | 2007-06-20 |
| DE602005022896D1 (de) | 2010-09-23 |
| BRPI0516754A (pt) | 2008-09-16 |
| NZ553848A (en) | 2010-01-29 |
| RU2382036C2 (ru) | 2010-02-20 |
| RU2007110479A (ru) | 2008-11-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20062491L (no) | Benzoksazinderivter og deres anvendelse | |
| NO20091893L (no) | Nye 1,4-benzotiepin-1,1-dioksidderivater som er substituert med benzylgrupper, fremgangsmater for fremstilling av medisiner inneholdende forbindelsene og anvendelse derav. | |
| NO20061839L (no) | Benzimidazolderivater, sammensetninger inneholdende dem, fremstilling derav, og anvendelse derav | |
| NO20052496L (no) | Selekterte CGRP antagonister, fremgangsmater for fremstilling derav og anvendelse derav som medikamenter. | |
| NO20052074L (no) | Substituerte benzoksazinoner og anvendelser derav. | |
| NO20072978L (no) | Nye betuinderivater, preparat derav og anvendelse derav | |
| NO20065904L (no) | Terapeutiske forbindelser | |
| NO20064166L (no) | Utvalgte CGRP-antagonister, deres fremstilling og deres anvendelse som medikanmenter | |
| NO20083434L (no) | Benzamid- og heteroarenderivater | |
| NO20072689L (no) | Tetrasykliske indolderivater som antivirale midler | |
| JO2353B1 (en) | New derivatives of mixed-ring fluoroglycosides and drugs containing these compounds and their use | |
| NO20062713L (no) | 2,6 bisheteroaryl-4-aminopyrimidiner som adenosin reseptor antagonister | |
| WO2006005609A3 (de) | Substituierte oxindol-derivate und diese enthaltende arzneimittel | |
| NO20052493L (no) | Selekterte CGRP antagonister, fremgangsmater for fremstilling derav og deres anvendelse som farmasoytiske sammensetninger. | |
| NO20060147L (no) | Benzimidazolderivater, sammensetninger som inneholder slike, fremstilling derav og anvendelse derav | |
| TW200642689A (en) | Immunosuppressive agent and anti-tumor agent comprising heterocyclic compound as active ingredient | |
| TW200626598A (en) | Pyrrazolo-pyrimidine derivatives | |
| NO20066055L (no) | Pyridinderivater | |
| NO20045486L (no) | Nye forbindelser og deres anvendelse | |
| NO20075169L (no) | Nye imidazo (1,5-A)pyndindenvater, fremgangsmate for fremstilling og farmasoytiske sammensetninger som inneholder samme. | |
| NO20082445L (no) | Neuropeptid-2 reseptor-agonister | |
| NO20060146L (no) | Benzimidazolderivater, sammensetninger som inneholder slike, fremstilling derav og anvendelse derav | |
| NO20065880L (no) | 3-Amino-l-arylpropylindoler som monoamin-gjenopptagelsesinhibitor | |
| WO2004039753A3 (en) | Phenyl compounds | |
| NO20054135L (no) | Kipolinon/benzoksazin derivater og anvendelser derav |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |